Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 21, Issue 1, 2003, Pages 91-94

  Jinnin, Masatoshi ^a   Ihn, Hironobu ^a   Yamane, Kenichi ^a   Asano, Yoshihide ^a   Yazawa, Norihito ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arthralgia; C reactive protein; Overlap

Indexed keywords

C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 0037282897     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. GENDI N, GORDON T, TANNER SB, BLACK CM: The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol 1992; 31: 783-6.
2. GENDI NS, WELSH KI, VAN VENROOIJ WJ, VANCHEESWARAN R, GILROY J, BLACK CM: HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum 1995; 38: 259-66.
3. ISENBERG D: Myositis in other connective tissue disorders. Clin Rheum Dis 1984; 10: 151-74.
4. CATOGGIO LJ, EVISON G, HARKNESS JA, MADDISON PJ: The arthropathy of systemic sclerosis (scleroderma); comparison with mixed connective tissue disease. Clin Exp Rheumatol 1983; 1: 101-12.
5. BARON M, SROLOVITZ H, LANDER P, KAPUSTA M: The coexistence of rheumatoid arthritis and scleroderma: A case report and review of the literature. J Rheumatol 1982; 9: 947-50.
6. COHEN MJ, PERSELLIN RH: Co-existence of rheuamtoid arthritis and systemic sclerosis in four patients. Scand J Rheumatol 1982; 11: 241-5.
7. HORIKI T, MORIUCHI J, TAKAYA M et al.: The coexistence of systemic sclerosis and rheumatoid arthritis in five patients: clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum 1996; 39: 152-56.
8. ZIMMERMANN C, STEINER G, SKRINER K, HASSFELD, W, PETERA P, SMOLEN JS: The concurrence of rheumatoid arthritis and limited systemic sclerosis. Arthritis Rheum 1998; 41: 1938-45.
9. LEROY EC, BLACK CM, FLEISCHMAJER R et al.: Sclerodrma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-6.
10. 2-GPI) in systemic sclerosis. Clin Exp Immunol 1998; 37: 1188-92.
11. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE ARA DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-9.
12. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
13. IHN H, SATO S, TAMAKI T et al.: Clinical evaluation of scleroderma spectrum disorders using a points system. Arch Dermatol Res 1992; 284: 391-5.
14. OTSUJI S, SHIBATA H, UMEDA M: Turbidimetric immunoassay of serum C-reactive protein. Clin Chem 1982; 28: 2121-4.
15. AILUS K, MELAMIES L, TUOMI T, PALOSUO T, AHO K: Measuring rheumatoid factor in non-rheumatoid subjects: Immunoturbidimetric assay, latex slide test, and enzyme-linked immunosorbent assay compared. Clin Chem 1991; 37: 1766-9.
16. KLEIN F, JANSSENS MB: Standardization of serological tests for rheumatoid factor measurement. Ann Rheum Dis 1987; 46: 674-80.
17. RODNAN GP: The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 1962; 56: 422-39.
18. TUFFANELLI DL, WINKELMANN RK: Systemic scleroderma: a clinical studies of 727 cases. Arch Dermatol 1961; 84: 359-71.
19. AHO K, PALOSUO T, KNEKT P, ALHA P, AROMAA A, HELIÖVAARA M: Serum C-reactive protein does not predict rheumatoid arthiritis. J Rheumatol 2000; 27: 1136-8.
20. PANAT MJ, WILLIAMS AL, O'SULLIVAN MM, LEWIS PA, COLES EC, JESSOP JD: Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 1473-7.
21. VANLEEUWEN MA, VAN DER HEIJDE DMFM, RIJSWIJK MH et al.: Interrelationships of outcome measures and process variables in early rheumatoid arthritis - a comparison of radiological damage, physical disability, joint counts and acute phase reactions. J Rheumatol 1994; 21: 425-9.
22. OTTERNESS IG: The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 1994; 24: 91-104.
23. WILLIAMS RC JR.: Symposium on the immunodiagnosis of rheumatic and related disease. Part II. Rheumatoid factors. Human Pathology 1983; 14: 386-91.
24. YOUNG A, VAN DER HEIJDE D: Can we predict aggressive disease? Baillieres Clin Rheumatol 1997; 11: 27-48.